Study | Cancer type | Activity type | Times per week | Duration | Minutes per week | Weeks | Total minutes | Timing of intervention | p Value |
---|---|---|---|---|---|---|---|---|---|
Adamsen et al25 | Mixed | Strength Cycling | 3 | 90 | 270 | 6 | 1620 | During treatment | 0.4 |
Courneya et al26 | Breast | Cycling | 3 | 15–35 | 45–105 | 15 | 1125 | After treatment | <0.01 |
Courneya et al27 | Colorectal | Walking Cycling Swimming | 4 | 25 | 100 | 16 | 1600 | After treatment | 0.68 |
Courneya et al28 | Breast | Cycling Running Elliptical Strength | 3 | 15–45 | 45–135 | 18 | 1580 | During treatment | 0.345 (RET) 0.286 (UC) |
Courneya et al29 | Lymphoma | Cycling | 3 | 20–40 | 60–120 | 12 | 1260 | During treatment | 0.039 |
Dimeo et al30 | Mixed | Cycling | 5 | 30 | 150 | 3 | 450 | During treatment | 0.67 |
Goedendorp et al31 | Mixed | Walking Cycling | 5 | 60 | 300 | 26 | 7800 | During treatment | 1.000 |
Milne et al32 | Breast | Cycling Rowing | 3 | 25 | 75 | 12 | 900 | After treatment | <0.001 |
Mutrie et al33 | Breast | Walking Cycling | 3 | 45 | 135 | 12 | 1620 | During treatment | 0.053 |
Andersen et al34 | Mixed | Cycling | 3 | 90 | 270 | 6 | 1620 | During treatment | 0.002 |
Cadmus et al35 | Breast | Walking | 5 | 30 | 150 | 26 | 3900 | During treatment | >0.05 |
Streckmann et al36 | Lymphoma | Cycling Stability | 2 | 60 | 120 | 36 | 4320 | During treatment | 0.03 |
Oldervoll et al37 | Mixed | Strength Stability | 2 | 60 | 120 | 8 | 960 | During treatment | 0.53 |
Samuel et al38 | Mixed | Walking Strength | 5 | 30 | 150 | 6 | 900 | During treatment | 0.014 |
Henke et al39 | Lung | Walking Strength | 5 | 20 | 100 | 65 | 6500 | During treatment | >0.05 |
Monga et al40 | Prostate | Walking | 3 | 50 | 150 | 8 | 1200 | During treatment | 0.04 |
RET, resistance exercise training; UC, usual care.